Chemistry:Enitociclib
From HandWiki
Enitociclib is an experimental drug that is being investigated for the treatment of cancer.[1] It is an inhibitor of the kinase CDK9.[2][3]
References
- ↑ "Enitociclib - Vincerx Pharma". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800044155.
- ↑ "CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies". Oncotarget 14: 749–752. August 2023. doi:10.18632/oncotarget.28473. PMID 37552223.
- ↑ "Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription". Cancer Research Communications 3 (11): 2268–2279. November 2023. doi:10.1158/2767-9764.CRC-23-0219. PMID 37882668.
 |  |
